Restoration of Enophthalmos in Anophthalmic Socket by HTR Polymer

Huang, Zei-Lun; Ma, Lih

doi:10.1097/01.iop.0000170410.23157.0e

Cited by 11 publications

(7 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One publication (8%) studied the frontal region ( 31 ). Further, there were five studies (42%) that included multiple facial regions ( 19 , 20 , 24 , 26 , 33 ).…”

Section: Resultsmentioning

confidence: 99%

Advancements in facial implantology: a review of hydroxyapatite applications and outcomes

Kauke-Navarro,

Knoedler,

Knoedler

et al. 2024

Front. Surg.

View full text Add to dashboard Cite

BackgroundThe search for an ideal bone substitute in reconstructive surgery has led to the exploration of various materials, with hydroxyapatite (HaP) emerging as a promising candidate due to its biocompatibility, osteoconductive properties, and structural similarity to human bone. Despite its potential, there is a paucity of data on the long-term safety and efficacy of HaP in facial skeletal reconstruction and augmentation.MethodsWe conducted a systematic review following PRISMA 2020 guidelines, searching PubMed/MEDLINE, Google Scholar, CENTRAL, and Web of Science databases for studies on hydroxyapatite facial implants in reconstruction and augmentation.ResultsOur search yielded 12 studies that met our inclusion criteria, encompassing 74 patients treated with HaP implants for various indications including facial fractures/defects, aesthetic facial balancing, and after tumor resection. The studies reported on outcomes such as implant integration, complications, aesthetic results, and patient satisfaction, with a general trend indicating positive outcomes for the use of HaP in facial reconstruction.ConclusionHydroxyapatite appears to be a viable and effective material for facial skeletal reconstruction and augmentation, offering benefits in terms of biocompatibility, osteoconductivity, and patient outcomes. However, limitations such as low mechanical strength and the need for further research on long-term safety and efficacy were identified. This review underscores the potential of HaP in craniofacial surgery while highlighting areas for future investigation.

show abstract

“…One publication (8%) studied the frontal region ( 31 ). Further, there were five studies (42%) that included multiple facial regions ( 19 , 20 , 24 , 26 , 33 ).…”

Section: Resultsmentioning

confidence: 99%

Advancements in facial implantology: a review of hydroxyapatite applications and outcomes

Kauke-Navarro,

Knoedler,

Knoedler

et al. 2024

Front. Surg.

View full text Add to dashboard Cite

show abstract

“…The orbital volume deficiency is most often characterized by a sunken appearance of the ocular prosthesis and a deepened upper eyelid sulcus. In patients with PEESS whose orbital implant is either too small or surrounding fat atrophy is found, the therapeutic options include the substitution of the orbital implant, the placement of an orbital floor implant, dermis fat grafting, or autologous fat transfers [9][10][11]. An adjunctive orbital volume can be achieved with fat pearls, fat boluses, hydrogel implants, soft tissue grafting, and composite fillers.…”

Section: Discussionmentioning

confidence: 99%

Hyaluronic acid injections in post-enucleation or evisceration socket syndrome: a case series

Migliardi¹,

Modugno²,

Chirico

et al. 2021

Eur J Plast Surg

View full text Add to dashboard Cite

Background One of the primary goals of enucleation and evisceration surgery is the restoration of an adequate orbital volume through the use of appropriately sized alloplastic or autogenous tissues. In patients inadequately treated, post-enucleation or evisceration socket syndrome occurs. Fillers are an ideal alternative for eyelid and eyebrow arcade volume enhancement since their injection is easily performed in an outpatient setting avoiding several complications. The aim of this study is to report the use of hyaluronic acid (HA) fillers to treat volume deficits of the upper and lower eyelids, projecting the brow arcade and reducing the asymmetry. Methods Thirteen patients (2 male, 11 female, mean age 32.7 years) were treated from June 2012 to May 2020. Non-surgical treatment by HA filler injection for aesthetic rehabilitation of deep superior sulcus, inferior tear trough deformity, and scleral show was performed. Results No complications as orbital-ache and/or vasovagal response were reported during the injections. Minor complications such as light swelling at the site of injection, self-resolved within 2 days, were recorded. Stable results were observed at follow-ups. In two cases, two successive treatments were required at 3 and 6 years from the first injection. Conclusions Hyaluronic acid fillers offer a versatile and safe method for replacing soft tissue lost from the upper eyelid/brow complex in cases of post-enucleation or evisceration socket syndrome. Level of evidence: Level IV, therapeutic study.

show abstract

“…Other injectable substances that have been discussed in the literature include cross-linked collagen, autologous fat, silicone oil, self-inflating hydrogel pellet expanders, and hard tissue replacement polymer. [5][6][7][8] Tañ ag and colleagues 9 recently described using injectable calcium phosphate cement in an animal model that proved to be a safe and effective material for orbital volume augmentation. The advantages of calcium hydroxylapatite include ease of application, a biocompatible product, a titratable volume of replacement, and the possibility of successive injections.…”

Section: Commentmentioning

confidence: 99%

Injectable Calcium Hydroxylapatite for Orbital Volume Augmentation

Vagefi

McMullan

Burroughs

et al. 2007

Archives of Facial Plastic Surgery

View full text Add to dashboard Cite

Injectable calcium hydroxylapatite provides a new, safe, simple, cost-effective technique to treat volume deficiency in the anophthalmic orbit. Augmentation achieved with this semipermanent filler has demonstrated a lasting effect in the orbit of 1 year or more with little volume loss. The filler seems to last longer in areas with less movement, blood supply, and lymphatic drainage. Injection can even be performed in an office setting using local anesthesia. The amount of volume replacement can be titrated, and the procedure is repeatable until adequate volume is obtained.

show abstract

Restoration of Enophthalmos in Anophthalmic Socket by HTR Polymer

Cited by 11 publications

References 7 publications

Advancements in facial implantology: a review of hydroxyapatite applications and outcomes

Advancements in facial implantology: a review of hydroxyapatite applications and outcomes

Hyaluronic acid injections in post-enucleation or evisceration socket syndrome: a case series

Injectable Calcium Hydroxylapatite for Orbital Volume Augmentation

Contact Info

Product

Resources

About